Cargando…
Using Medicare Data to Assess the Proarrhythmic Risk of Non-Cardiac Treatment Drugs that Prolong the QT Interval in Older Adults: An Observational Cohort Study
INTRODUCTION: Serious cardiac arrhythmias caused by QT-prolonging drugs are difficult to predict based on physiological measurement and pre-approval clinical trials. Post-marketing surveillance and monitoring are important to generate safety data. OBJECTIVES: To assess whether an observational study...
Autores principales: | Fung, Kin Wah, Baye, Fitsum, Kapusnik-Uner, Joan, McDonald, Clement J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875170/ https://www.ncbi.nlm.nih.gov/pubmed/33569737 http://dx.doi.org/10.1007/s40801-021-00230-1 |
Ejemplares similares
-
Nirmatrelvir and Molnupiravir and Post–COVID-19 Condition in Older Patients
por: Fung, Kin Wah, et al.
Publicado: (2023) -
Investigation of the Proarrhythmic Effects of Antidepressants according to QT Interval, QT Dispersion and T Wave Peak-to-End Interval in the Clinical Setting
por: Okayasu, Hiroaki, et al.
Publicado: (2019) -
Prevention of Pazopanib-Induced Prolonged Cardiac Repolarization and
Proarrhythmic Effects
por: Akman, Tulay, et al.
Publicado: (2014) -
Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US
por: Fung, Kin Wah, et al.
Publicado: (2023) -
Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)